Energy homeostasis in the bone

[1]  M. Zaiss,et al.  L-arginine metabolism inhibits arthritis and inflammatory bone loss , 2023, Annals of the Rheumatic Diseases.

[2]  Qi Guo,et al.  Bone marrow immune cells respond to fluctuating nutritional stress to constrain weight regain. , 2023, Cell metabolism.

[3]  Y. Jiang,et al.  Correlation of lipocalin 2 and glycolipid metabolism and body composition in a large cohort of children with osteogenesis imperfecta , 2023, Journal of endocrinological investigation.

[4]  Hui Peng,et al.  Senescent immune cells accumulation promotes brown adipose tissue dysfunction during aging , 2023, Nature communications.

[5]  Kuan-Wen Wu,et al.  Denosumab Attenuates Glucolipotoxicity-Induced β-Cell Dysfunction and Apoptosis by Attenuating RANK/RANKL Signals , 2023, International journal of molecular sciences.

[6]  D. Mellström,et al.  Low Circulating Valine Associate With High Risk of Hip Fractures , 2023, The Journal of clinical endocrinology and metabolism.

[7]  S. Zhao,et al.  Denosumab and incidence of type 2 diabetes among adults with osteoporosis: population based cohort study , 2023, BMJ.

[8]  Wenjun Xie,et al.  Extracellular Calcium-Induced Calcium Transient Regulating the Proliferation of Osteoblasts through Glycolysis Metabolism Pathways , 2023, International journal of molecular sciences.

[9]  Satoru Otsuru,et al.  Mitochondrial β-oxidation of adipose-derived fatty acids by osteoblasts fuels parathyroid hormone–induced bone formation , 2023, JCI insight.

[10]  O. Werz,et al.  Mediterranean Diet component oleic acid increases protective lipid-mediators and improves trabecular bone in a Porphyromonas-gingivalis-inoculation-model. , 2022, Journal of clinical periodontology.

[11]  P. Li,et al.  HSP90β promotes osteoclastogenesis by dual-activation of cholesterol synthesis and NF-κB signaling , 2022, Cell Death & Differentiation.

[12]  Alaa A. A. Aljabali,et al.  The Warburg effect in osteoporosis: Cellular signaling and epigenetic regulation of energy metabolic events to targeting the osteocalcin for phenotypic alteration. , 2022, Cellular signalling.

[13]  J. Jeong,et al.  Sclerostin aggravates insulin signaling in skeletal muscle and hepatic steatosis via upregulation of ER stress by mTOR‐mediated inhibition of autophagy under hyperlipidemic conditions , 2022, Journal of cellular physiology.

[14]  Jingyun Yang,et al.  Ammonia promotes the proliferation of bone marrow-derived mesenchymal stem cells by regulating the Akt/mTOR/S6k pathway , 2022, Bone Research.

[15]  Guiqian Chen,et al.  Wnt signaling: Essential roles in osteoblast differentiation, bone metabolism and therapeutic implications for bone and skeletal disorders , 2022, Genes & diseases.

[16]  F. Farzadfar,et al.  Association of amino acid metabolites with osteoporosis, a metabolomic approach: Bushehr elderly health program , 2022, Metabolomics.

[17]  Soo-Young Lee,et al.  BCAT1 promotes osteoclast maturation by regulating branched-chain amino acid metabolism , 2022, Experimental & Molecular Medicine.

[18]  Hui Peng,et al.  A mechanosensitive lipolytic factor in the bone marrow promotes osteogenesis and lymphopoiesis. , 2022, Cell metabolism.

[19]  Lisha Li,et al.  RNA sequencing profiles reveal dynamic signaling and glucose metabolic features during bone marrow mesenchymal stem cell senescence , 2022, Cell & bioscience.

[20]  Yang Li,et al.  MFN2 knockdown promotes osteogenic differentiation of iPSC-MSCs through aerobic glycolysis mediated by the Wnt/β-catenin signaling pathway , 2022, Stem cell research & therapy.

[21]  Zhipeng Chen,et al.  Gut microbiota and metabonomics used to explore the mechanism of Qing’e Pills in alleviating osteoporosis , 2022, Pharmaceutical biology.

[22]  Chunmei Zhang,et al.  Dysfunction of metabolic activity of bone marrow mesenchymal stem cells in aged mice , 2022, Cell proliferation.

[23]  Ziheng Wei,et al.  Metabolomics Coupled with Pathway Analysis Provides Insights into Sarco-Osteoporosis Metabolic Alterations and Estrogen Therapeutic Effects in Mice , 2021, Biomolecules.

[24]  Yun Tian,et al.  Relationship Between Serum Amino Acid Levels and Bone Mineral Density: A Mendelian Randomization Study , 2021, Frontiers in Endocrinology.

[25]  M. Taketo,et al.  Bone‐derived sclerostin and Wnt/β‐catenin signaling regulate PDGFRα+ adipoprogenitor cell differentiation , 2021, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[26]  Hui Peng,et al.  Senescent immune cells release grancalcin to promote skeletal aging. , 2021, Cell metabolism.

[27]  A. Masood,et al.  A Distinctive Human Metabolomics Alteration Associated with Osteopenic and Osteoporotic Patients , 2021, Metabolites.

[28]  D. Mellström,et al.  Serum glycine levels are associated with cortical bone properties and fractures risk in men. , 2021, The Journal of clinical endocrinology and metabolism.

[29]  M. Abshirini,et al.  Potential modulatory mechanisms of action by long-chain polyunsaturated fatty acids on bone cell and chondrocyte metabolism. , 2021, Progress in lipid research.

[30]  Xiangqi Li,et al.  Osteoclasts May Affect Glucose Uptake-Related Insulin Resistance by Secreting Resistin , 2021, Diabetes, metabolic syndrome and obesity : targets and therapy.

[31]  M. Tomita,et al.  A Metabolomic Profile Predictive of New Osteoporosis or Sarcopenia Development , 2021, Metabolites.

[32]  M. Schiller,et al.  Identification and Functional Characterization of Metabolites for Bone Mass in Peri-/Post-menopausal Chinese Women. , 2021, The Journal of clinical endocrinology and metabolism.

[33]  F. Montecucco,et al.  Circulating Levels of Sclerostin Predict Glycemic Improvement after Sleeve Gastrectomy , 2021, Nutrients.

[34]  S. Pang,et al.  Lipocalin-2: a role in hepatic gluconeogenesis via AMP-activated protein kinase (AMPK) , 2021, Journal of Endocrinological Investigation.

[35]  Haemin Kim,et al.  Regulation of Osteoclast Differentiation and Activity by Lipid Metabolism , 2021, Cells.

[36]  B. Dawson,et al.  Nitric oxide modulates bone anabolism through regulation of osteoblast glycolysis and differentiation. , 2020, The Journal of clinical investigation.

[37]  J. You,et al.  Glutamine metabolite α-ketoglutarate acts as an epigenetic co-factor to interfere with osteoclast differentiation. , 2020, Bone.

[38]  P. Carmeliet,et al.  Glutamine Metabolism in Osteoprogenitors Is Required for Bone Mass Accrual and PTH‐Induced Bone Anabolism in Male Mice , 2020, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[39]  L. Liang,et al.  Association between the metabolome and bone mineral density in a Chinese population , 2020, EBioMedicine.

[40]  I. Nissim,et al.  Malic Enzyme Couples Mitochondria with Aerobic Glycolysis in Osteoblasts , 2020, Cell reports.

[41]  U. Schlötzer-Schrehardt,et al.  Osteocyte necrosis triggers osteoclast-mediated bone loss through macrophage-inducible C-type lectin. , 2020, The Journal of clinical investigation.

[42]  E. Abel,et al.  Both aerobic glycolysis and mitochondrial respiration are required for osteoclast differentiation , 2020, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[43]  M. V. Vander Heiden,et al.  Increased demand for NAD+ relative to ATP drives aerobic glycolysis , 2020, bioRxiv.

[44]  M. Prideaux,et al.  Taurine, an osteocyte metabolite, protects against oxidative stress-induced cell death and decreases inhibitors of the Wnt/β-catenin signaling pathway. , 2020, Bone.

[45]  T. Ohnishi,et al.  Glut1 expression is increased by p53 reduction to switch metabolism to glycolysis during osteoblast differentiation. , 2020, The Biochemical journal.

[46]  S. Gancheva,et al.  Are Bisphosphonates Associated with Adverse Metabolic and Cognitive Effects? A Study in Intact Rats and Rats Fed High-Fat High-Fructose Diet , 2020, Calcified Tissue International.

[47]  Aristeidis G. Telonis,et al.  Lactate Efflux From Intervertebral Disc Cells Is Required for Maintenance of Spine Health , 2020, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[48]  Jörg Menche,et al.  Environmental arginine controls multinuclear giant cell metabolism and formation , 2020, Nature Communications.

[49]  P. Carmeliet,et al.  Lipid availability determines skeletal progenitor cell fate via SOX9 , 2020, Nature.

[50]  Ji-Eun Kim,et al.  Atherogenic diet-induced bone loss is primarily due to increased osteoclastogenesis in mice. , 2020, The Journal of nutritional biochemistry.

[51]  Elizabeth J. Atkinson,et al.  Identification of osteoclast-osteoblast coupling factors in humans reveals links between bone and energy metabolism , 2020, Nature Communications.

[52]  I. Reid,et al.  Zoledronate Slows Weight Loss and Maintains Fat Mass in Osteopenic Older Women: Secondary Analysis of a Randomized Controlled Trial , 2020, Calcified Tissue International.

[53]  Leyao Shen,et al.  Biphasic regulation of glutamine consumption by WNT during osteoblast differentiation , 2020, Journal of Cell Science.

[54]  M. McGee-Lawrence,et al.  Kynurenine suppresses osteoblastic cell energetics in vitro and osteoblast numbers in vivo , 2019, Experimental Gerontology.

[55]  Y. Takashi,et al.  Effect of denosumab, a human monoclonal antibody of receptor activator of nuclear factor kappa-B ligand (RANKL), upon glycemic and metabolic parameters , 2019, Medicine.

[56]  Xiao-lin Zhang,et al.  Uncarboxylated osteocalcin ameliorates hepatic glucose and lipid metabolism in KKAy mice via activating insulin signaling pathway , 2019, Acta Pharmacologica Sinica.

[57]  M. Wolf,et al.  FGF23 at the crossroads of phosphate, iron economy and erythropoiesis , 2019, Nature Reviews Nephrology.

[58]  Ryohei Kono,et al.  Teriparatide Improves Bone and Lipid Metabolism in a Male Rat Model of Type 2 Diabetes Mellitus , 2019, Endocrinology.

[59]  E. Douni,et al.  RANKL inhibition improves muscle strength and insulin sensitivity and restores bone mass. , 2019, The Journal of clinical investigation.

[60]  A. Hayes,et al.  Rapamycin Affects Palmitate-Induced Lipotoxicity in Osteoblasts by Modulating Apoptosis and Autophagy. , 2019, The journals of gerontology. Series A, Biological sciences and medical sciences.

[61]  B. Troen,et al.  Treatment with an inhibitor of fatty acid synthase attenuates bone loss in ovariectomized mice. , 2019, Bone.

[62]  Baochang Cai,et al.  Integrated metallomic and metabolomic profiling of plasma and tissues provides deep insights into the protective effect of raw and salt-processed Achyranthes bidentata Blume extract in ovariectomia rats. , 2019, Journal of ethnopharmacology.

[63]  O. Mäkitie,et al.  Osteoporosis and skeletal dysplasia caused by pathogenic variants in SGMS2 , 2019, JCI insight.

[64]  Leyao Shen,et al.  Glutamine Metabolism Regulates Proliferation and Lineage Allocation in Skeletal Stem Cells. , 2019, Cell metabolism.

[65]  J. Stanik,et al.  The Bone Markers Sclerostin, Osteoprotegerin, and Bone-Specific Alkaline Phosphatase Are Related to Insulin Resistance in Children and Adolescents, Independent of Their Association with Growth and Obesity , 2019, Hormone Research in Paediatrics.

[66]  H. Kitaura,et al.  Docosahexaenoic Acid Inhibits Inflammation-Induced Osteoclast Formation and Bone Resorption in vivo Through GPR120 by Inhibiting TNF-α Production in Macrophages and Directly Inhibiting Osteoclast Formation , 2019, Front. Endocrinol..

[67]  L. Mei,et al.  Lrp4 expression by adipocytes and osteoblasts differentially impacts sclerostin's endocrine effects on body composition and glucose metabolism , 2019, The Journal of Biological Chemistry.

[68]  M. Kruger,et al.  Free fatty acid receptor 4-β-arrestin 2 pathway mediates the effects of different classes of unsaturated fatty acids in osteoclasts and osteoblasts. , 2019, Biochimica et biophysica acta. Molecular and cell biology of lipids.

[69]  Takahito Otani,et al.  Osteocalcin triggers Fas/FasL-mediated necroptosis in adipocytes via activation of p300 , 2018, Cell Death & Disease.

[70]  R. Trivedi,et al.  Glucose dependent miR-451a expression contributes to parathyroid hormone mediated osteoblast differentiation. , 2018, Bone.

[71]  G. Loots,et al.  Vhl deficiency in osteocytes produces high bone mass and hematopoietic defects. , 2018, Bone.

[72]  A. Feizi,et al.  Alendronate improves fasting plasma glucose and insulin sensitivity, and decreases insulin resistance in prediabetic osteopenic postmenopausal women: A randomized triple‐blind clinical trial , 2018, Journal of diabetes investigation.

[73]  Mi Yang,et al.  Long noncoding RNA Bmncr regulates mesenchymal stem cell fate during skeletal aging , 2018, The Journal of clinical investigation.

[74]  Zhenwen Zhang,et al.  The decline of whole-body glucose metabolism in ovariectomized rats , 2018, Experimental Gerontology.

[75]  Fanxin Long,et al.  Notch signaling suppresses glucose metabolism in mesenchymal progenitors to restrict osteoblast differentiation , 2018, The Journal of clinical investigation.

[76]  Sung-jin Kim,et al.  Cytoprotective Effect of Taurine against Hydrogen Peroxide-Induced Oxidative Stress in UMR-106 Cells through the Wnt/β-Catenin Signaling Pathway , 2018, Biomolecules & therapeutics.

[77]  Xi-Long Zheng,et al.  HDL impairs osteoclastogenesis and induces osteoclast apoptosis via upregulation of ABCG1 expression , 2018, Acta biochimica et biophysica Sinica.

[78]  M. Brand,et al.  Osteoblast‐like MC3T3‐E1 Cells Prefer Glycolysis for ATP Production but Adipocyte‐like 3T3‐L1 Cells Prefer Oxidative Phosphorylation , 2018, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[79]  F. Lang,et al.  Insulin suppresses the production of fibroblast growth factor 23 (FGF23) , 2018, Proceedings of the National Academy of Sciences.

[80]  J. Fonollá,et al.  Effects of Daily Intake of Calcium and Vitamin D-Enriched Milk in Healthy Postmenopausal Women: A Randomized, Controlled, Double-Blind Nutritional Study. , 2018, Journal of women's health.

[81]  E. Vittinghoff,et al.  Effect of denosumab on fasting glucose in women with diabetes or prediabetes from the FREEDOM trial , 2018, Diabetes/metabolism research and reviews.

[82]  J. Tanner,et al.  The Proline Cycle As a Potential Cancer Therapy Target. , 2018, Biochemistry.

[83]  E. Mercken,et al.  Vhl deletion in osteoblasts boosts cellular glycolysis and improves global glucose metabolism , 2018, The Journal of clinical investigation.

[84]  Ayumu Takeno,et al.  Glucose uptake inhibition decreases expressions of receptor activator of nuclear factor-kappa B ligand (RANKL) and osteocalcin in osteocytic MLO-Y4-A2 cells. , 2018, American journal of physiology. Endocrinology and metabolism.

[85]  D. Mougiakakos,et al.  Short-chain fatty acids regulate systemic bone mass and protect from pathological bone loss , 2018, Nature Communications.

[86]  T. Shlomi,et al.  Temporal fluxomics reveals oscillations in TCA cycle flux throughout the mammalian cell cycle , 2017, Molecular systems biology.

[87]  Xiuxia Qu,et al.  Lactate induces osteoblast differentiation by stabilization of HIF1α , 2017, Molecular and Cellular Endocrinology.

[88]  Caitlyn E. Bowman,et al.  Fatty acid oxidation by the osteoblast is required for normal bone acquisition in a sex- and diet-dependent manner. , 2017, JCI insight.

[89]  M. Trajkovski,et al.  Bone Regulates Browning and Energy Metabolism Through Mature Osteoblast/Osteocyte PPARγ Expression , 2017, Diabetes.

[90]  M. Kruger,et al.  Palmitoleic Acid Inhibits RANKL-Induced Osteoclastogenesis and Bone Resorption by Suppressing NF-κB and MAPK Signalling Pathways , 2017, Nutrients.

[91]  M. Rubin,et al.  MC4R-dependent suppression of appetite by bone-derived lipocalin 2 , 2017, Nature.

[92]  W. Lu,et al.  Aging Reduces an ERRalpha‐Directed Mitochondrial Glutaminase Expression Suppressing Glutamine Anaplerosis and Osteogenic Differentiation of Mesenchymal Stem Cells , 2017, Stem cells.

[93]  S. Avnet,et al.  Energy metabolism in osteoclast formation and activity. , 2016, The international journal of biochemistry & cell biology.

[94]  T. Clemens,et al.  Glucose Transporter-4 Facilitates Insulin-Stimulated Glucose Uptake in Osteoblasts. , 2016, Endocrinology.

[95]  P. Carmeliet,et al.  HIF-1α Promotes Glutamine-Mediated Redox Homeostasis and Glycogen-Dependent Bioenergetics to Support Postimplantation Bone Cell Survival. , 2016, Cell metabolism.

[96]  A. Gaudio,et al.  Denosumab Inhibition of RANKL and Insulin Resistance in Postmenopausal Women with Osteoporosis , 2015, Calcified Tissue International.

[97]  T. Spector,et al.  Amino Acid Intakes Are Associated With Bone Mineral Density and Prevalence of Low Bone Mass in Women: Evidence From Discordant Monozygotic Twins , 2015, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[98]  E. Kennedy,et al.  Oxidation of the aromatic amino acids tryptophan and tyrosine disrupts their anabolic effects on bone marrow mesenchymal stem cells , 2015, Molecular and Cellular Endocrinology.

[99]  C. Ricordi,et al.  Osteocalcin Effect on Human β-Cells Mass and Function. , 2015, Endocrinology.

[100]  L. Richiardi,et al.  Effect of intermittent PTH treatment on plasma glucose in osteoporosis: A randomized trial. , 2015, Bone.

[101]  C. Jenkinson,et al.  Sclerostin and Insulin Resistance in Prediabetes: Evidence of a Cross Talk Between Bone and Glucose Metabolism , 2015, Diabetes Care.

[102]  Shin-Yoon Kim,et al.  A Medium-Chain Fatty Acid, Capric Acid, Inhibits RANKL-Induced Osteoclast Differentiation via the Suppression of NF-κB Signaling and Blocks Cytoskeletal Organization and Survival in Mature Osteoclasts , 2014, Molecules and cells.

[103]  G. Karsenty,et al.  Osteocalcin Promotes β-Cell Proliferation During Development and Adulthood Through Gprc6a , 2014, Diabetes.

[104]  F. Kronenberg,et al.  Blockade of receptor activator of nuclear factor-κB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus , 2013, Nature Medicine.

[105]  Huiliang Xie,et al.  Earlier Onset and Greater Severity of Disordered Mineral Metabolism in Diabetic Patients With Chronic Kidney Disease , 2012, Diabetes Care.

[106]  M. McKee,et al.  Endocrine Regulation of Energy Metabolism by the Skeleton , 2007, Cell.

[107]  K. Jordan,et al.  THE EPIDEMIOLOGY OF OSTEOPOROSIS , 1996, The British journal of clinical practice.

[108]  M. Wolfgang,et al.  &bgr;-Catenin Directs Long-Chain Fatty Acid Catabolism in the Osteoblasts of Male Mice , 2018, Endocrinology.